Antinociceptive properties of fadolmidine (MPV-2426), a novel α2-adrenoceptor agonist

CNS Drug Reviews

Volumn 10, Issue 2, 2004, Pages 117-126

  Pertovaara, Antti ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Antinociception; Fadolmidine; MPV 2426; Radolmidine; 2 Adrenoceptor agonist

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DEXMEDETOMIDINE; RADOLMIDINE;

ANTINOCICEPTION; BINDING AFFINITY; BLOOD BRAIN BARRIER; CARDIOVASCULAR DISEASE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG RECEPTOR BINDING; EXPERIMENTAL ANIMAL; HEMODYNAMIC MONITORING; HUMAN; INJECTION SITE; MOTONEURON; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; POSTGANGLIONIC NERVE; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PAIN; REVIEW; SEDATION; SPINAL ANESTHESIA; TAIL FLICK TEST; VISCERAL PAIN;

EID: 3042736047     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2004.tb00008.x     Document Type: Review

References (36)

1. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996;64:493-501.
2. Clark FM. Proudfit HK. Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons. Brain Res 1992;591:44-53.
3. Davis KD, Treede RD, Raja SN, Meyer RA, Campbell JN. Topical application of clonidine relieves hyperalgesia in patients with sympathetically maintained pain. Pain 1991;47:309-317.
4. 2-adrenoceptors affect sleep and arousal mechanisms. Br J Pharmacol 1987;90:675-685.
5. 2-adrenergic agonist, MPV-2426, in sheep. Anesthesiology 1999;91:1425-1436.
6. 2C-adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. J Pharmacol Exp Ther 2002;300:282-290.
7. Hunter JC, Fontana DJ, Hedley LR, et al. Assessment of the role of α2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 1997;122:1339-1344.
8. 2- Adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons, Anesthesiology 2003;98:682-689.
9. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-363.
10. Kingery WS, Davies MF, Maze M. Molecular mechanisms for the analgesic properties of alpha-2 adrenergic agonists. In: Borsook D, Ed. Molecular Neurobiology of Pain. Seattle: IASP Press, 1997;275-304.
11. 2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception. Eur J Pharmacol 2003;468:183-189.
12. 2A-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic and anesthetic-sparing responses in vivo. Proc Natl Acad Sci USA 1997;94:9950-9955.
13. 2-adrenergic agonist for spinal analgesia. Fund Clin Pharmacol 1999;13(Suppl 1):380.
14. 2A-Adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes. J Pharmacol Exp Ther 2001;299:939-944.
15. 2 receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine. Br J Pharmacol 2001;132:1827-1836.
16. 2A-Adrenoceptors contribute to feedback inhibition of capsaicin-induced hyperalgesia. Anesthesiology 2004; In press.
17. 2C- adrenergic receptors. J Neurosci 2003;23:6837-6846.
18. 2-adrenoceptor agonist, in a rat model of postoperative pain. Anesthesiology 2000;92:1740-1745.
19. 2-adrenoceptor agonist, following intrathecal administration in the rat. Acta Anaesthesiol Scand 2000;44:1077-1082.
20. 2-adrenergic receptors. J Neurophysiol 2002;87:1938-1947.
21. 2-adrenoceptor agonists, with special emphasis on medetomidine studies, Prog Neurobiol 1993;40:691-709.
22. Pertovaara A, Kalmari J. Comparison of the visceral antinociceptive effects of spinally administered MPV-2426 (fadohnidine) and clonidine in the rat. Anesthesiology 2003;98:189-194.
23. 2-adrenoceptor agonist, MPV-2426, following intrathecal application in neuropathic rats. Anesthesiology, 2000;92:1082-1092.
24. 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats. Pain 1994;57:207-215.
25. 2-adrenergic mechanisms in the medetomidine-induced antinociception. Neuroscience 1991;44:705-714.
26. Proudfit HK. Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. Prog Brain Res 1988;77:357-370.
27. Sato J, Perl ER. Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 1991;251:1608-1610.
28. Spaulding TC, Venafro JJ, Ma MG, Fielding S. The dissociation of the antinociceptive effect of clonidine from supraspinal structures. Neuropharmacology 1979;18:103-105.
29. 2A-agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci 1997;17:7157-7165.
30. Talke P, Xu M, Paloheimo M, Kalso E. Effects of intrathecally administered dexmedetomidine, MPV-2426 and tizanidine on EMG in rats. Acta Anaesthesiol Scand 2003;47:347-354.
31. 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci USA 2002;99:12471-12476.
32. 2-adrenergic antinociception in neuropathic animals. Neuroscience 2002;114:655-668.
33. Westlund KN, Carlton SM, Zhang D, Willis WD. Direct catecholaminergic innervation of primate spinothalamic tract neurons. J Comp Neurol 1990;299:178-186.
34. 2-adrenergic agonist, compared with dexmedetomidine in different pain models in the rat. Anesthesiology 2000;93:473-481.
35. 2-adrenoceptor agonist, MPV-2426, in the locus coeruleus in the rat. Acta Anaesthesiol Scand 2000;44:648-655.
36. Yaksh TL. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav 1985;22:845-858.